
Scientia Vascular
Innovative neurovascular devices utilizing advanced micromachining for precise clot removal and smoother navigation.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
* | $14.0m | Late VC | |
Total Funding | 000k |
Related Content
Scientia Vascular, founded in 2007 and headquartered in Salt Lake City, specializes in developing advanced neurovascular devices. The company leverages cutting-edge micromachining technology to create high-precision guidewires and catheters, primarily serving healthcare providers in the neurovascular treatment space. Their flagship products, such as the Colossus Guidewire and the 38 Aspiration Catheter, are designed to minimize the ledge effect and enhance navigation through the vasculature, thereby improving clot removal outcomes. Scientia Vascular operates in the medical technology market, focusing on innovation and quality to maintain a competitive edge. The company generates revenue through the sale of its FDA-cleared medical devices, targeting hospitals and specialized medical centers. Key milestones include the FDA clearance of their first product in 2014 and subsequent advancements in microfabrication technology. The company benefits from its strategic location in Salt Lake City, which offers access to a rich talent pool and a burgeoning medical technology sector.
Keywords: neurovascular, micromachining, guidewires, catheters, clot removal, FDA-cleared, medical devices, innovation, healthcare, Salt Lake City.